What are the 2026 diagnostic criteria for fibromyalgia in adults, including symptom duration, required pain distribution, Widespread Pain Index (WPI) and Symptom Severity (SS) score thresholds, and exclusion of other conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Fibromyalgia in 2026

The 2016 ACR revised fibromyalgia diagnostic criteria remain the current standard in 2026, requiring: (1) Widespread Pain Index (WPI) ≥7 AND Symptom Severity Scale (SSS) ≥5, OR WPI 3-6 AND SSS ≥9; (2) generalized pain in at least 4 of 5 body regions; (3) symptoms present at similar level for at least 3 months; and (4) no other disorder that would otherwise explain the pain. 1

Core Diagnostic Components

Pain Assessment Requirements

The WPI measures the number of painful body regions from 0-19 possible sites, including:

  • Shoulder girdle (left and right)
  • Upper and lower arms (left and right)
  • Upper and lower legs (left and right)
  • Hip (left and right)
  • Jaw (left and right)
  • Chest, abdomen, upper back, lower back, neck

The most commonly affected regions are the shoulder girdles (88-89%), upper back (85%), and neck (82%). 2

Generalized Pain Criterion (Critical Addition)

A key modification in the 2016 criteria was adding the "generalized pain" requirement to prevent misclassification of regional pain syndromes. This requires pain in at least 4 of 5 defined regions:

  • Left upper region
  • Right upper region
  • Left lower region
  • Right lower region
  • Axial region

This modification eliminated false-positives from regional pain disorders while still identifying 98.8% of true fibromyalgia cases. 1, 3

Symptom Severity Scale (SSS)

The SSS ranges from 0-12 and assesses:

  • Fatigue severity (0-3)
  • Waking unrefreshed (0-3)
  • Cognitive symptoms (0-3)
  • Sum of somatic symptoms (0-3), including headaches, pain/cramps in lower abdomen, and depression

Each component is scored on a 0-3 scale (0=no problem, 1=slight, 2=moderate, 3=severe).

Temporal Requirement

Symptoms must be present at a similar level for at least 3 months. 1

Exclusion Criterion

The presence of another disorder does NOT exclude fibromyalgia diagnosis unless that disorder fully explains the pain. This represents a critical clarification from earlier criteria—fibromyalgia can coexist with other conditions. 1

Alternative Diagnostic Pathways

Two Qualifying Combinations

Patients can meet criteria through either:

  1. High pain distribution pathway: WPI ≥7 AND SSS ≥5
  2. High symptom severity pathway: WPI 3-6 AND SSS ≥9

The second pathway acknowledges that some patients have fewer pain sites but severe systemic symptoms. 1, 4

Polysymptomatic Distress Scale (PSD)

An alternative simplified approach combines WPI + SSS into a single 0-31 scale. A PSD score ≥12-13 can effectively identify fibromyalgia when combined with self-reported chronic widespread pain. 5, 6

Clinical Application Considerations

Physician vs. Self-Report Versions

The physician-based criteria are valid for individual patient diagnosis in clinical practice. The self-report questionnaire version is valid for research studies but should not be used for clinical diagnosis in individual patients without physician assessment. 1

Performance Characteristics

Against the 1990 ACR classification criteria, the 2016 criteria demonstrate:

  • Median sensitivity: 86%
  • Median specificity: 90%

These represent excellent agreement given the definitional differences between classification systems. 1

Common Diagnostic Pitfalls

Approximately 25% of patients with established fibromyalgia may not satisfy criteria at any single assessment due to symptom variability. 4 This emphasizes the importance of:

  • Assessing symptoms over time rather than at a single visit
  • Recognizing that symptom severity fluctuates
  • Not excluding fibromyalgia based on one negative assessment

Regional pain syndromes (shoulder pain, low back pain) can be misclassified as fibromyalgia if the generalized pain criterion is not applied. Always verify pain is present in at least 4 of 5 body regions. 1, 3

Gender and Emotional State Considerations

Women report more severe pain and numbness than men. 2 Patients with anxiety show more widespread pain (higher WPI), while those with depression show similar pain distribution but different pain qualities. 2, 7 These factors affect symptom presentation but do not change diagnostic thresholds.

Diagnostic Label Reality

Only 25% of individuals meeting fibromyalgia criteria actually receive a diagnostic label in clinical practice. 8 Factors associated with receiving a diagnosis include female sex, lower education, psychiatric comorbidities, higher healthcare utilization, and employment status. This suggests significant underdiagnosis in real-world settings.

Practical Diagnostic Algorithm

  1. Screen for chronic widespread pain (≥3 months duration)
  2. Verify generalized pain distribution (≥4 of 5 body regions)
  3. Calculate WPI (count painful regions from 0-19)
  4. Calculate SSS (sum fatigue, unrefreshed sleep, cognitive symptoms, somatic symptoms; 0-12)
  5. Apply diagnostic thresholds: (WPI ≥7 AND SSS ≥5) OR (WPI 3-6 AND SSS ≥9)
  6. Confirm no alternative explanation fully accounts for symptoms

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.